Market open
$
20.59
Change
-0.42 -1.98%
Volume
Volume 122,414
Aug 16, 2022, 10:14 a.m.
Real time quotes
Previous close
$ 21.01
$ 20.59
Change
-0.42 -1.98%
Day low
Day high
$20.50
$21.49

52 week low
52 week high
$10.48
$21.49

Market cap
$1.29B
Average volume
589,210
P/E ratio
N/A
Rev. per Employee
$393,877
EPS
-1.70
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on KDNY
-
Chinook Therapeutics started at buy with $30 stock price target at Stifel Nicolaus
- Tomi Kilgore
-
Green Plains, Quotient Technology See Activist Action
- Barron's Online
-
Chinook Therapeutics initiated at Wedbush at outperform with $28 price target
- Tonya Garcia
-
Chinook Therapeutics started at outperform with $32 stock price target at Evercore ISI
- Tomi Kilgore
-
Chinook Therapeutics upgraded to outperform from perform at Oppenheimer
- Tomi Kilgore
-
Chinook Therapeutics started at outperform with $38 stock price target at SVB Leerink
- Tomi Kilgore
-
Aduro Biotech downgraded to perform from outperform at Oppenheimer
- Tomi Kilgore
-
Harvard’s Stockpickers Are Beating Yale’s
- Barron's Online
-
Aduro Biotech started at outperform with $15 stock price target at Oppenheimer
- Tomi Kilgore
-
Why Biotech Looks Like a Good Bet in 2017
- Barron's Online
-
Dow, S&P 500 close higher, lifted by surge in mergers
- Anora Mahmudova
-
Aduro Biotech stock drops 22% after patient tested positive for listeria
- Emma Court
-
Aduro Biotech says FDA put trials on partial clinical hold after patient tested positively for listeria
- Emma Court
-
Aduro Biotech halted after patient in clinical trial tested positive for listeria
- Emma Court
-
Aduro's stock resumes trade, tumbles 35% premarket after disappointing trial results
- Tomi Kilgore
-
Aduro Biotech said late-stage pancreatic cancer drug missed primary endpoint
- Emma R. Court
-
Aduro Biotech shares halted in premarke trade
- Ciara Linnane
-
Aduro Biotech started at outperform with $30 stock price target at Cowen & Co.
- Tomi Kilgore
- Loading more headlines...
Analyst Ratings
Other News on KDNY
-
Samsara BioCapital, LLC's Top 5 Buys of the 2nd Quarter
- GuruFocus.com
-
Chinook Therapeutics (KDNY) Investor Presentation - Slideshow
- Seeking Alpha
-
10-Q: CHINOOK THERAPEUTICS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Checking Out Chinook Therapeutics
- Seeking Alpha
- Loading more headlines...
Press Releases on KDNY
-
Chinook Therapeutics to Present at Upcoming Investor Conferences
- GlobeNewswire
-
Chinook Therapeutics Announces Proposed Public Offering
- GlobeNewswire
-
FRX Innovations Commences Trading on the TSX Venture Exchange
- TheNewswire.ca
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com